QuiVad

Home / Funds / Voleon Capital Management LP

Voleon Capital Management LP

The short positions this fund discloses today, across every market.

Follow

Open short positions, the heaviest first.
IssuerMarket% of capitalSince
B&M European Value Retail S.A.Germany0.79%April 20, 2026
Oryzon Genomics, S.A.Spain0.60%October 5, 2026
Tubacex, S.A.Spain0.60%October 30, 2026
Genuit Group plcGermany0.54%October 20, 2026
Atos GroupFrance0.50%October 21, 2026
Mips ABSweden0.50%October 21, 2026

Follow by RSS

Get the moves on Voleon Capital Management LP by mail, at most once a day.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

6,010 disclosures on record for this fund.
DateIssuerMarket% of capitalEnd of publication
May 2, 2023Hansa Biopharma ABSweden0.68%
May 2, 2023Saipem SPAItaly0.55%
April 28, 2023Nokian RenkaatFinland0.69%
April 28, 2023Saipem SPAItaly0.60%
April 27, 2023Hansa Biopharma ABSweden0.70%
April 25, 2023Nokian RenkaatFinland0.58%
April 24, 2023Nokian RenkaatFinland0.64%
April 21, 2023Hansa Biopharma ABSweden0.61%
April 20, 2023Saipem SPAItaly0.55%
April 18, 2023Fugro N.V.Netherlands0.60%
April 13, 2023Nokian RenkaatFinland0.69%
April 13, 2023EuroAPIFrance0.66%July 3, 2023
April 12, 2023Nokian RenkaatFinland0.76%
April 6, 2023Hansa Biopharma ABSweden0.53%
April 5, 2023Fugro N.V.Netherlands0.58%
April 5, 2023Zealand Pharma A/SDenmark0.45%April 5, 2023
April 4, 2023Zealand Pharma A/SDenmark0.50%April 4, 2023
April 4, 2023Saipem SPAItaly0.33%
April 3, 2023EuroAPIFrance0.70%July 3, 2023
March 30, 2023Nokian RenkaatFinland0.80%
March 30, 2023Saipem SPAItaly0.68%
March 30, 2023Laboratorios Farmaceuticos Rovi, S.A.Spain0.47%
March 28, 2023Laboratorios Farmaceuticos Rovi, S.A.Spain0.51%
March 27, 2023QT GroupFinland0.49%
March 23, 2023Nokian RenkaatFinland0.79%
March 21, 2023Hansa Biopharma ABSweden0.50%
March 20, 2023Nokian RenkaatFinland0.81%
March 17, 2023EuroAPIFrance0.61%July 3, 2023
March 17, 2023Fugro N.V.Netherlands0.61%
March 15, 2023Nokian RenkaatFinland0.70%
March 14, 2023Nokian RenkaatFinland0.66%
March 13, 2023Saipem SPAItaly0.84%
March 10, 2023Fugro N.V.Netherlands0.54%
March 10, 2023EuroAPIFrance0.52%July 3, 2023
March 10, 2023Nokian RenkaatFinland0.50%
March 8, 2023Saipem SPAItaly0.70%
March 7, 2023Fugro N.V.Netherlands0.60%
March 3, 2023Saipem SPAItaly0.61%
March 1, 2023Oncopeptides ABSweden0.68%
March 1, 2023Solutions 30 SEFrance0.47%March 3, 2023
February 28, 2023QT GroupFinland0.51%
February 27, 2023Saipem SPAItaly0.55%
February 24, 2023Oncopeptides ABSweden0.76%
February 24, 2023Fugro N.V.Netherlands0.50%
February 21, 2023Oncopeptides ABSweden0.88%
February 21, 2023Laboratorios Farmaceuticos Rovi, S.A.Spain0.51%
February 17, 2023Oncopeptides ABSweden0.98%
February 15, 2023Oncopeptides ABSweden1.09%
February 8, 2023Oncopeptides ABSweden1.10%
February 6, 2023Solutions 30 SEFrance0.53%March 3, 2023

Download 6,010 filings as CSV Columns: Date, Issuer, Market, Disclosed position, Unit, End date. The other formats

The funds short on the same companies

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Voleon Capital Management LP, data as at October 30, 2026, https://www.quivad.com/detenteur/voleon-capital-management-lp?page=32